Variations of P wave duration and dispersion in patients treated with periodic hemodialysis

Authors

Abstract

Introduction: P wave duration and dispersion are noninvasive markers for the prediction of atrial fibrillation risk in patients treated with hemodialysis.

Objective: To determine P wave variations and dispersion in patients with stage 5 chronic kidney disease treated with periodic hemodialysis.

Method: A longitudinal, observational, prospective study was carried out from October 2016 to April 2018.

Results: Seventy-one patients (47 males) were included, averaging 56 years of age; P wave duration at the beginning of hemodialysis was 75.91 milliseconds and at the end was 81.2; p<0.001. Maximum P wave increased from 95.25 to 101.16 milliseconds; p<0.001. P wave dispersion did not show significant changes. In patients with more than one-year arteriovenous fistula, P wave dispersion increased from 35 milliseconds to 43.6 at the end of hemodialysis, with no significant differences. Increases in maximum P wave duration were significant regardless of smaller or larger left atrial size. P wave dispersion did not show significant differences when compared with left atrial size. Thrombolysis percentage in Group II was higher than 50% in most of the centers.

Conclusions: P wave dispersion did not show significant changes during hemodialysis as has been observed in different international studies. Average/maximum P wave duration show significant increases that are probably the expression of changes in the heterogeneity of atrial conduction in the sample studied.

Downloads

Download data is not yet available.

Author Biographies

Rafael E. Cruz Abascal, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”.

Servicio de Nefrología

Alejandro E. Gutiérrez Hernández, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”.

Servicio de Nefrología

Dayana Brito Varea, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”.

Servicio de Nefrología

Elibet Chávez González, Cardiocentro Ernesto Che Guevara. Villa Clara

Departamento de estimulación cardiaca y Electrofisiología.

References

1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe [Internet]. Brussels: International Society of Nephrology [citado 3 Sep 2020]; 2017. Disponible en: http://www.nephro.ru/content/files/news/GKHAtlas_ISN_17.pdf

2. González-Bedat MC, Rosa-Diez G, Fernández-Cean JM, Ordúñez P, Ferreiro A, Douthat W. Los registros nacionales de diálisis y trasplante renal en América Latina: cómo implementarlos y mejorarlos. Rev Panam Salud Publica. 2015;38(3):254-60.

3. Bencomo Rodríguez O. Enfermedad Renal Crónica: prevenirla, mejor que tratarla. Rev Cuban Med Gen Integr [Internet]. 2015 [citado 3 Sep 2020];31(3). Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/66/24

4. Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, et al. Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica. Nefrologia. 2014;34(3):273-424. DOI: https://doi.org/10.3265/Nefrologia.pre2014.Feb.12464

5. Herrera Valdés R. Enfermedad renal crónica: enfoque sistémico epidemiológico-clínico e intersectorial. En: Alfonso Guerra JP. Nefrología. La Habana: Editorial Ciencias Médicas; 2016. p. 102-29.

6. Cuba. Centro Nacional de Información de Ciencias Médicas. Biblioteca Médica Nacional. Enfermedad Renal Crónica. Factores de Riesgo. Bibliomed [Internet]. 2017 [citado 4 Sep 2020];24(4). Disponible en: http://files.sld.cu/bmn/files/2017/04/bibliomed-abril-2017.pdf

7. Escamilla-Cejudo JA, Lara Báez J, Peña R, Ruiz Luna PL, Ordunez P. Optimización del registro de muerte por enfermedad renal crónica en las comunidades agrícolas de América Central. Rev Panam Salud Publica. 2016;40(5):285-93.

8. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7-A8. DOI: https://doi.org/10.1053/j.ajkd.2016.12.004

9. Weiner DE, Nicholls AJ, Sarnak MJ. Enfermedad Cardiovascular. En: Daugirdas JT, Blake PG, Todd S. Manual de Diálisis. 4a Ed. Filadelfia: Lippincott Williams & Wilkins; 2007. p. 453-66.

10. Aquiles Jara C. Calcificaciones vasculares en pacientes con insuficiencia renal crónica. Rev Med Clin Condes. 2012;23(6):715-23. DOI: https://doi.org/10.1016/S0716-8640(12)70373-5

11. Guerra Bustillo GJ. Complicaciones cardiacas. En: Magrans Buch Ch, Barranco Hernández E, Ibars Bolaños EV. Hemodiálisis y Enfermedad Renal Crónica. La Habana: Editorial Ciencias Médicas; 2016. p. 319-50.

12. Faulkner A, Garrett A. Effect of gender on P-wave dispersion in asymptomatic populations. Int SportMed J [Internet]. 2013 [citado 5 Sep 2020];14(4):236-44. Disponible en: https://hdl.handle.net/10520/EJC146797

13. Marchlinski F. Taquiarritmias. En: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison Principios de Medicina Interna. 18ª Ed. Nueva York: McGraw-Hill; 2012. p. 1881-2.

14. Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis [Internet]. 2016 [citado 6 Sep 2020];5:2048004016639443. Disponible en: https://doi.org/10.1177/2048004016639443

15. Acampa M, Lazzerini PE, Martini G. How to identify patients at risk of silent atrial fibrillation after cryptogenic stroke: Potential role of P wave dispersion. J Stroke. 2017;19(2):239-41. DOI: https://doi.org/10.5853/jos.2016.01620

16. Drighil A, Madias JE, El Mosalami H, El Badaoui N, Mouine B, Fadili W, et al. Impact of hemodialysis on P-wave amplitude, duration, and dispersion. Indian Pacing Electrophysiol J. 2007;7(2):85-96.

17. Szabó Z, Kakuk G, Fülöp T, Mátyus J, Balla J, Kárpáti I, et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant. 2002;17(9):1634-8. DOI: https://doi.org/10.1093/ndt/17.9.1634

18. Páll A, Czifra Á, Sebestyén V, Becs G, Kun C, Balla J, et al. Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram. Int Urol Nephrol. 2016;48(2):271-7. DOI: https://doi.org/10.1007/s11255-015-1144-4

19. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135(5 Pt 1):733-8. DOI: https://doi.org/10.1016/s0002-8703(98)70030-4

20. Pérez-Riera AR, de Abreu LC, Barbosa-Barros R, Grindler J, Fernandes-Cardoso A, Baranchuk A. P-wave dispersion: an update. Indian Pacing Electrophysiol J. 2016;16(4):126-33.

21. Censi F, Corazza I, Reggiani E, Calcagnini G, Mattei E, Triventi M, et al. P-wave Variability and Atrial Fibrillation. Sci Rep [Internet]. 2016 [citado 10 Sep 2020];6:26799. Disponible en: https://doi.org/10.1038/srep26799

22. Chen SC, Su HM, Huang JC, Chang K, Tsai YC, Chen LI, et al. Association of P-Wave Dispersion with Overall and Cardiovascular Mortality in Hemodialysis Patients. Am J Nephrol. 2015;42(3):198-205. DOI: https://doi.org/10.1159/000440776

23. Kollu K, Altintepe L, Duran C, Topal M, Ecirli S. The assessment of P-wave dispersion and myocardial repolarization parameters in patients with chronic kidney disease. Ren Fail. 2018;40(1):1-7. DOI: https://doi.org/10.1080/0886022x.2017.1419962

24. Akin F, Firatli I, Katkat F, Gurmen T, Ayca B, Kalyoncuoglu M, et al. P-wave dispersion and its relationship with the severity of the disease in patients with stable coronary artery disease. North Clin Istanb [Internet]. 2014 [citado 10 Sep 2020];1(2):65-70. Disponible en: https://doi.org/10.14744/nci.2014.25733

25. Giese A, Ornek A, Kurucay M, Kara K, Wittkowski H, Gohar F, et al. P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany. Int J Med Sci. 2014;11(11):1140-6. DOI: https://doi.org/10.7150/ijms.9444

Published

2021-10-09

How to Cite

1.
Cruz Abascal RE, Gutiérrez Hernández AE, Brito Varea D, Chávez González E. Variations of P wave duration and dispersion in patients treated with periodic hemodialysis. CorSalud [Internet]. 2021 Oct. 9 [cited 2025 Jun. 22];13(4):429-35. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/674

Issue

Section

ORIGINAL ARTICLES